Steven E. Nissen, MD, lead author of the study “Bempedoic Acid And Cardiovascular Outcomes In Statin-Intolerant Patients,” answers questions on the importance of his team’s research on bempedoic acid, how...
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
In this interview, Jacob C. Jentzer, MD, Assistant Professor of Medicine in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota discusses the implications of his study and...
Andres Pineda Maldonado, MD, from the University of Florida, Jacksonville, answers our questions about new therapies for mitral valve disease, the different recommendations for men vs women, and more.
The Consumer Technology Association and Heart Rhythm Society have released new guidance on the best practices for consumers who use wearable devices. Lead author Nassir F. Marrouche, MD, from Tulane...
Sean L. Zheng, BM, BCh, MA, MRCP, of King’s College Hospital NHS Foundation Trust, discusses key clinical takeaways from his new study, which provided evidence of the benefits and risks of aspirin for...
A recent study highlighted a link between the use of fluoroquinolones, a commonly prescribed class of antibiotic, and the risk of aortic and mitral regurgitation. Consultant360 spoke with Mahyar Etminan,...
Brendan M. Everett, MD, MPH, from Harvard Medical School answers our questions about his session at the World Congress Insulin Resistance Diabetes & Cardiovascular Disease conference.
A new study examined the connection between mental health conditions and hypertension among US women. Consultant360 spoke with the lead author of the study for more information.
